Ashton JJ, Beattie RM. Personalised therapy for inflammatory bowel disease. Lancet. 2019;393(10182):1672–4.
Ng SC, Shi HY, Hamidi N, Underwood FE, Tang W, Benchimol EI, Panaccione R, Ghosh S, Wu JCY, Chan FKL, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet. 2017;390(10114):2769–78.
Atreya R, Neurath MF. Biomarkers for personalizing IBD Therapy: the Quest continues. Clin Gastroenterol Hepatol; 2024.
Brzozowski B, Mazur-Bialy A, Pajdo R, Kwiecien S, Bilski J, Zwolinska-Wcislo M, Mach T, Brzozowski T. Mechanisms by which stress affects the experimental and clinical inflammatory bowel disease (IBD): role of Brain-Gut Axis. Curr Neuropharmacol. 2016;14(8):892–900.
Gracie DJ, Guthrie EA, Hamlin PJ, Ford AC. Bi-directionality of brain-gut interactions in patients with inflammatory bowel disease. Gastroenterology. 2018;154(6):1635–46. e1633.
Fairbrass KM, Lovatt J, Barberio B, Yuan Y, Gracie DJ, Ford AC. Bidirectional brain-gut axis effects influence mood and prognosis in IBD: a systematic review and meta-analysis. Gut. 2022;71(9):1773–80.
Gao X, Cao Q, Cheng Y, Zhao D, Wang Z, Yang H, Wu Q, You L, Wang Y, Lin Y, et al. Chronic stress promotes colitis by disturbing the gut microbiota and triggering immune system response. Proc Natl Acad Sci U S A. 2018;115(13):E2960–9.
Komoto M, Asada A, Ohshima Y, Miyanaga K, Morimoto H, Yasukawa T, Morito K, Takayama K, Uozumi Y, Nagasawa K. Dextran sulfate sodium-induced colitis in C57BL/6J mice increases their susceptibility to chronic unpredictable mild stress that induces depressive-like behavior. Life Sci. 2022;289:120217.
Banfi D, Moro E, Bosi A, Bistoletti M, Cerantola S, Crema F, Maggi F, Giron MC, Giaroni C, Baj A. Impact of Microbial metabolites on Microbiota-Gut-Brain Axis in Inflammatory Bowel Disease. Int J Mol Sci 2021, 22(4).
Zois CD, Katsanos KH, Kosmidou M, Tsianos EV. Neurologic manifestations in inflammatory bowel diseases: current knowledge and novel insights. J Crohns Colitis. 2010;4(2):115–24.
Hall CV, Radford-Smith G, Savage E, Robinson C, Cocchi L, Moran RJ. Brain signatures of chronic gut inflammation. Front Psychiatry. 2023;14:1250268.
Ge L, Liu S, Li S, Yang J, Hu G, Xu C, Song W. Psychological stress in inflammatory bowel disease: psychoneuroimmunological insights into bidirectional gut-brain communications. Front Immunol. 2022;13:1016578.
Kim JS, Chen MH, Wang HE, Lu CL, Wang YP, Zhang B. Inflammatory bowel disease and neurodegenerative diseases. Gut Liver. 2023;17(4):495–504.
Seaton N, Hudson J, Harding S, Norton S, Mondelli V, Jones ASK, Moss-Morris R. Do interventions for mood improve inflammatory biomarkers in inflammatory bowel disease? A systematic review and meta-analysis. EBioMedicine. 2024;100:104910.
Graham DB, Xavier RJ. Pathway paradigms revealed from the genetics of inflammatory bowel disease. Nature. 2020;578(7796):527–39.
Furey TS, Sethupathy P, Sheikh SZ. Redefining the IBDs using genome-scale molecular phenotyping. Nat Rev Gastroenterol Hepatol. 2019;16(5):296–311.
Jia K, Shen J. Transcriptome-wide association studies associated with Crohn’s disease: challenges and perspectives. Cell Biosci. 2024;14(1):29.
Zhu S, Lin Y, Ding Z. Exploring inflammatory bowel disease therapy targets through druggability genes: a mendelian randomization study. Front Immunol. 2024;15:1352712.
Zou M, Liang Q, Zhang W, Zhu Y, Xu Y. Endoplasmic reticulum stress related genome-wide mendelian randomization identifies therapeutic genes for ulcerative colitis and Crohn’s disease. Front Genet. 2023;14:1270085.
Wingo AP, Liu Y, Gerasimov ES, Gockley J, Logsdon BA, Duong DM, Dammer EB, Robins C, Beach TG, Reiman EM, et al. Integrating human brain proteomes with genome-wide association data implicates new proteins in Alzheimer’s disease pathogenesis. Nat Genet. 2021;53(2):143–6.
Wingo AP, Fan W, Duong DM, Gerasimov ES, Dammer EB, Liu Y, Harerimana NV, White B, Thambisetty M, Troncoso JC, et al. Shared proteomic effects of cerebral atherosclerosis and Alzheimer’s disease on the human brain. Nat Neurosci. 2020;23(6):696–700.
Wang D, Liu S, Warrell J, Won H, Shi X, Navarro FCP, Clarke D, Gu M, Emani P, Yang YT et al. Comprehensive functional genomic resource and integrative model for the human brain. Science 2018, 362(6420).
Fromer M, Roussos P, Sieberts SK, Johnson JS, Kavanagh DH, Perumal TM, Ruderfer DM, Oh EC, Topol A, Shah HR, et al. Gene expression elucidates functional impact of polygenic risk for schizophrenia. Nat Neurosci. 2016;19(11):1442–53.
Liu JZ, van Sommeren S, Huang H, Ng SC, Alberts R, Takahashi A, Ripke S, Lee JC, Jostins L, Shah T, et al. Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations. Nat Genet. 2015;47(9):979–86.
Gusev A, Ko A, Shi H, Bhatia G, Chung W, Penninx BW, Jansen R, de Geus EJ, Boomsma DI, Wright FA, et al. Integrative approaches for large-scale transcriptome-wide association studies. Nat Genet. 2016;48(3):245–52.
Skrivankova VW, Richmond RC, Woolf BAR, Davies NM, Swanson SA, VanderWeele TJ, Timpson NJ, Higgins JPT, Dimou N, Langenberg C, et al. Strengthening the reporting of observational studies in epidemiology using mendelian randomisation (STROBE-MR): explanation and elaboration. BMJ. 2021;375:n2233.
Storm CS, Kia DA, Almramhi MM, Bandres-Ciga S, Finan C, Hingorani AD, Wood NW, International Parkinson’s Disease Genomics C. Finding genetically-supported drug targets for Parkinson’s disease using mendelian randomization of the druggable genome. Nat Commun. 2021;12(1):7342.
Bonaz BL, Bernstein CN. Brain-gut interactions in inflammatory bowel disease. Gastroenterology. 2013;144(1):36–49.
Sun Y, Li L, Xie R, Wang B, Jiang K, Cao H. Stress triggers flare of inflammatory bowel disease in children and adults. Front Pediatr. 2019;7:432.
Osadchiy V, Martin CR, Mayer EA. The gut-brain Axis and the Microbiome: mechanisms and clinical implications. Clin Gastroenterol Hepatol. 2019;17(2):322–32.
Petruo VA, Krauss E, Kleist A, Hardt J, Hake K, Peirano J, Krause T, Ehehalt R, von Arnauld P, Buning J, et al. Perceived distress, personality characteristics, coping strategies and psychosocial impairments in a national German multicenter cohort of patients with Crohn’s disease and ulcerative colitis. Z Gastroenterol. 2019;57(4):473–83.
Tong X, Wu J, Sun R, Li H, Hong Y, Liu X, Sun Y, Chen C, Huang L, Lin S. Elevated dorsal medial prefrontal cortex to lateral habenula pathway activity mediates chronic stress-induced depressive and anxiety-like behaviors. Neuropsychopharmacology 2024.
Zhang Z, Liu L, Zhang H, Li C, Chen Y, Zhang J, Pan C, Cheng S, Yang X, Meng P, et al. The genetic structure of pain in depression patients: a genome-wide association study and proteome-wide association study. J Psychiatr Res. 2022;156:547–56.
Wei W, Zhang H, Cheng B, Qin X, He D, Zhang N, Zhao Y, Cai Q, Shi S, Chu X, et al. Identification of novel functional brain proteins for treatment-resistant schizophrenia: based on a proteome-wide association study. Eur Psychiatry. 2023;66(1):e33.
Cheng B, Meng P, Yang X, Cheng S, Liu L, Jia Y, Wen Y, Zhang F. Integrated analysis of proteome-wide and transcriptome-wide association studies identified novel genes and chemicals for vertigo. Brain Commun. 2022;4(6):fcac313.
Cook I, Wang T, Leyh TS. Tetrahydrobiopterin regulates monoamine neurotransmitter sulfonation. Proc Natl Acad Sci U S A. 2017;114(27):E5317–24.
Vuralli D, Arslan B, Topa E, de Morais AL, Gulbahar O, Ayata C, Bolay H. Migraine susceptibility is modulated by food triggers and analgesic overuse via sulfotransferase inhibition. J Headache Pain. 2022;23(1):36.
Zhao XH, Zhao P, Deng Z, Yang T, Qi YX, An LY, Sun DL, He HY. Integrative analysis reveals marker genes for intestinal mucosa barrier repairing in clinical patients. iScience. 2023;26(6):106831.
Wang R, Wang G. Protein modification and autophagy activation. Adv Exp Med Biol. 2019;1206:237–59.
Ehrentraut SF, Colgan SP. Implications of protein post-translational modifications in IBD. Inflamm Bowel Dis. 2012;18(7):1378–88.
Peng B, Zhao H, Keerthisinghe TP, Yu Y, Chen D, Huang Y, Fang M. Gut microbial metabolite p-cresol alters biotransformation of bisphenol A: enzyme competition or gene induction? J Hazard Mater. 2022;426:128093.
Neish AS, Gewirtz AT, Zeng H, Young AN, Hobert ME, Karmali V, Rao AS, Madara JL. Prokaryotic regulation of epithelial responses by inhibition of IkappaB-alpha ubiquitination. Science. 2000;289(5484):1560–3.
Kelly D, Campbell JI, King TP, Grant G, Jansson EA, Coutts AG, Pettersson S, Conway S. Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-gamma and RelA. Nat Immunol. 2004;5(1):104–12.
Pan ZQ, Kentsis A, Dias DC, Yamoah K, Wu K. Nedd8 on cullin: building an expressway to protein destruction. Oncogene. 2004;23(11):1985–97.
Curtis VF, Ehrentraut SF, Campbell EL, Glover LE, Bayless A, Kelly CJ, Kominsky DJ, Colgan SP. Stabilization of HIF through inhibition of Cullin-2 neddylation is protective in mucosal inflammatory responses. FASEB J. 2015;29(1):208–15.
MacManus CF, Campbell EL, Keely S, Burgess A, Kominsky DJ, Colgan SP. Anti-inflammatory actions of adrenomedullin through fine tuning of HIF stabilization. FASEB J. 2011;25(6):1856–64.
Liu J, Zhang X, Zhang Y, Qian M, Yang M, Yang S, Wang L. Farnesyl diphosphate synthase exacerbates nonalcoholic steatohepatitis via the activation of AHR-CD36 axis. FASEB J. 2023;37(7):e23035.
Camarillo GF, Goyon EI, Zuniga RB, Salas LAS, Escarcega AEP, Yamamoto-Furusho JK. Gene Expression Profiling of Mediators Associated with the inflammatory pathways in the intestinal tissue from patients with Ulcerative Colitis. Mediators Inflamm. 2020;2020:9238970.
Chu FF, Esworthy RS, Shen B, Gao Q, Doroshow JH. Dexamethasone and Tofacitinib suppress NADPH oxidase expression and alleviate very-early-onset ileocolitis in mice deficient in GSH peroxidase 1 and 2. Life Sci. 2019;239:116884.
Add Comment